What Happened?. Shares of genetic testing company Myriad Genetics (NASDAQ. MYGN) jumped 3.7% in the afternoon session after the company signed an exclusive agreement with Zydus Lifesciences to commercialize a trio of its cancer tests in India... .
What Happened?. Shares of genetic testing company Myriad Genetics (NASDAQ. MYGN) fell 6% in the afternoon session after the U.S ... The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks ... .